Cargando…
DWI scalp dot sign: superficial temporal artery restricted diffusion in giant cell arteritis
Autores principales: | Taylor, Eleanor, Tona, Francesca, Singh-Curry, Victoria, Venter, Marius, Carulli, Maresa, Tench, Colin, Youngstein, Taryn, Dixon, Luke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070058/ https://www.ncbi.nlm.nih.gov/pubmed/36048888 http://dx.doi.org/10.1093/rheumatology/keac502 |
Ejemplares similares
-
Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020) -
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022) -
Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021) -
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply
por: Esen, Idil, et al.
Publicado: (2022) -
Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply
por: Stamatis, Pavlos, et al.
Publicado: (2021)